je.st
news
Tag: merck
Bayer Said to Be in Exclusive Talks for Merck Consumer Unit
2014-05-02 12:26:31| Chemicals - Topix.net
Bayer AG is in exclusive talks to acquire Merck & Co.' s consumer business and is prepared to pay about $14 billion for the division, people with knowledge of the matter said.
Tags: unit
consumer
exclusive
talks
Merck Mulls Sale\nOf Coppertone
2014-04-29 16:36:06| Happi Breaking News
Will sell consumer healthcare unit for $14B.
Tags: merck
mulls
coppertone
Merck Q1 Profit Up 7 Pct. Despite Sales Decline
2014-04-29 14:34:01| Biotech - Topix.net
Major cost cuts enabled drugmaker Merck & Co. to offset continuing generic competition cutting sales of former blockbuster medicines.
Tags: sales
profit
decline
pct
Merck Announces First-Quarter 2014 Financial Results
2014-04-29 13:00:00| Merck.com - Financial News
Dateline City: WHITEHOUSE STATION, N.J. First-Quarter 2014 Non-GAAP EPS of $0.88, Excluding Certain Items; GAAP EPS of $0.57; Confirms 2014 Full-Year Non-GAAP EPS Target of $3.35 to $3.53, Excluding Certain Items; GAAP EPS Range of $2.15 to $2.47 Worldwide Sales were $10.3 Billion, a Decrease of 4 Percent, Reflecting Unfavorable Impact of Patent Expiries and a 2 Percent Unfavorable Impact from Foreign Exchange Strategic Initiatives Drove Cost Reductions and Portfolio Divestitures, Generating First-Quarter 2014 Benefits Sales of REMICADE, SIMPONI and ISENTRESS, as well as Diabetes and Vaccines Franchises Grew FDA Approved GRASTEK and RAGWITEK Sublingual Allergen Extract Immunotherapy Tablets and Accepted Filings for V503 and Suvorexant; Company Announced Progress in Key Clinical Programs Including HCV and HIV Repurchased $7.5 Billion of Common Stock Over Previous 12 Months as Part of Ongoing Share Repurchase Program WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2014. Language: English Contact: MerckMedia:Steve Cragle, 908-423-3461Lainie Keller, 908-423-4187orInvestors:Joe Romanelli, 908-423-5185Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
financial
announces
merck
Merck to Hold Investor Briefing at Boston Research Facility
2014-04-28 13:30:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold an Investor Briefing on Tuesday, May 6, 2014 starting at 9:00 a.m. EDT at its research facility in Boston, MA. During the event, members of Merck's senior management will detail the company's research strategy, showcase candidates from the research and development pipeline and provide a business update. Language: English Contact: MerckMedia:Ian McConnell, 908-423-3046orInvestor:Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: research
hold
boston
facility
Sites : [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] next »